State of the art of prostatic arterial embolization for benign prostatic hyperplasia

Petrillo, Mario; Pesapane, Filippo; Fumarola, Enrico Maria; Emili, Ilaria; Acquasanta, Marzia; Patella, Francesca; Angileri, Salvatore Alessio; Rossi, Umberto; Piacentini, Igor; Granata, Antonio Maria; Ierardi, Anna Maria

doi:10.21037/gs.2018.03.01

Cited by 18 publications

(13 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PAE results in improved IPSS, PVR, and QMax, though TURP has been shown to be significantly more effective at relieving LUTS and improving objective measurements than PAE. In some studies, PAE has also been shown to have more adverse events and complications than TURP, specifically when considering postprocedure retention and treatment failure rates [119,120]. A "post-PAE syndrome" has also been described, consisting of perineal pain, nausea, vomiting, and dysuria.…”

Section: Prostatic Artery Embolization (Pae)mentioning

confidence: 99%

Management of BPH and LUTS

Brucker

Katz

Siev

2020

Design and Implementation of the Modern Men’s Health Center

View full text Add to dashboard Cite

Section: Prostatic Artery Embolization (Pae)mentioning

confidence: 99%

Management of BPH and LUTS

Brucker

Katz

Siev

2020

Design and Implementation of the Modern Men’s Health Center

View full text Add to dashboard Cite

“…In recent years, wide visibility has gained the use of multimodality imaging in cancer diseases (4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). Magnetic resonance imaging (MRI) has shown high diagnostic accuracy, as an independent method for adequate disease rule-out, in effectively targeting the biopsy, in association with other clinical parameters such as PSA, for the evaluation of PSA density (PSAD), to increase sensitivity in identifying clinically significant (cs) lesions or cancer recurrence after specific therapy (21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32).…”

Section: Introductionmentioning

confidence: 99%

Biparametric (bp) and multiparametric (mp) magnetic resonance imaging (MRI) approach to prostate cancer disease: a narrative review of current debate on dynamic contrast enhancement

et al. 2020

View full text Add to dashboard Cite

Prostate cancer is the most common malignancy in male population. Over the last few years, magnetic resonance imaging (MRI) has proved to be a robust clinical tool for identification and staging of clinically significant prostate cancer. Though suggestions by the European Society of Urogenital Radiology to use complete multiparametric (mp) T2-weighted/diffusion weighted imaging (DWI)/dynamic contrast enhancement (DCE) acquisition for all prostate MRI examinations, the real advantage of functional DCE remains a matter of debate. Recent studies demonstrate that biparametric (bp) and mp approaches have similar accuracy, but controversial evidences remain, and the specific potential benefits of contrast medium administration are still poorly discussed in literature. The bp approach is in fact sufficient in most cases to adequately identify a negative test, or to accurately define the degree of aggressiveness of a lesion, especially if larger or with major characteristics of malignancy. This feature would give the DCE a secondary role, probably limited to a second evaluation of the lesion location, for detecting small cancer or in case of controversy. However, DCE has proved to increase the sensitivity of prostate MRI, though a less specificity.Therefore, an appropriate decision algorithm is needed to standardize the MRI approach. Aim of this review study was to provide a schematic description of bpMRI and mpMRI approaches in the study of prostatic anatomy, focusing on comparative validity and current DCE application. Additional theoretical considerations on prostate MRI are provided.

show abstract

“…For years, Trans-Rectal Ultrasound Guided biopsy (TRUS-Gb) has been the gold standard for the detection of prostate cancer in men with increased level of PSA or positive Digital Rectal Examination (DRE). The development of more and more sophisticated methods for the diagnosis and treatment (18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29) of prostate cancer, Multiparametric MRI in the management of prostate cancer: an update-a narrative review including imaging, led to focusing more on the detection rather than on the staging of this disease. At the same time, the advent of the Multiparametric MRI allowed to do a step forward in the detection process.…”

Section: Introductionmentioning

confidence: 99%

Multiparametric MRI in the management of prostate cancer: an update—a narrative review

et al. 2020

View full text Add to dashboard Cite

The growing interest in multiparametric MRI is leading to important changes in the diagnostic process of prostate cancer. MRI-targeted biopsy is likely to become a standard for the diagnosis of prostate cancer in the next years. Despite it is well known that MRI has no role as a staging technique, it is clear that multiparametric MRI may be of help in active surveillance protocols. Noteworthy, MRI in active surveillance is not recommended, but a proper understanding of its potential may be of help in achieving the goals of a delayed treatment strategy. Moreover, the development of minimally invasive techniques, like laparoscopic and robotic surgery, has led to greater expectations as regard to the functional outcomes of radical prostatectomy. Multiparametric MRI may play a role in planning surgical strategies, with the aim to provide the highest oncologic outcome with a minimal impact on the quality of life. We maintain that a proper anatomic knowledge of prostate lesions may allow the surgeon to achieve a better result in planning as well as in performing surgery and help the surgeon and the patient engage in a shared decision in planning a more effective strategy for prostate cancer control and treatment. This review highlights the advantages and the limitations of multiparametric MRI in prostate cancer diagnosis, in active surveillance and in planning surgery.

show abstract

State of the art of prostatic arterial embolization for benign prostatic hyperplasia

Cited by 18 publications

References 55 publications

Management of BPH and LUTS

Management of BPH and LUTS

Biparametric (bp) and multiparametric (mp) magnetic resonance imaging (MRI) approach to prostate cancer disease: a narrative review of current debate on dynamic contrast enhancement

Multiparametric MRI in the management of prostate cancer: an update—a narrative review

Contact Info

Product

Resources

About